Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: Chronic kidney disease increases the risk of acute myocardial infarction and worsens outcomes. Despite advances in care, mortality rate disparities regarding gender, race and socioeconomic status persist. This study examines trends in acute myocardial infarction-related mortality among chronic kidney disease patients in the United States from 1999 to 2020.
Methods: We analyzed mortality data from the CDC WONDER database, identifying deaths with acute myocardial infarction (International Classification of Diseases, 10th Revision [ICD-10] codes I21-I22) as the underlying cause and chronic kidney disease (ICD-10 N18) as a contributing cause. Age-adjusted mortality rates per 100,000, standardized to the 2000 US population, were calculated and stratified by sex, race/ethnicity, urbanization, and state. Trends were assessed using Joinpoint regression to estimate annual percentage change with 95% confidence intervals.
Results: A total of 72,780 acute myocardial infarction-related deaths in chronic kidney disease patients aged 25-85 years occurred from 1999 to 2020. The age adjusted mortality rate declined from 2.46 in 1999 to 0.99 in 2020 (annual percent change: -4.09; 95% CI -5.54 to -2.60). Men had higher mortality than women (age adjusted mortality rate: 2.11 vs. 1.13). Non-Hispanic Black individuals had the highest age adjusted mortality rate (2.90). Nonmetropolitan areas showed higher rates than metropolitan areas (1.63 vs. 1.51). A significant increase in mortality was observed among Hispanic patients from 2015 to 2020 (annual percent change: 8.15; 95% CI 1.13-15.65).
Conclusions: Acute myocardial infarction-related mortality in chronic kidney disease patients has declined overall, but persistent disparities by sex, race/ethnicity, and geography highlight the need for continued efforts and targeted interventions in this high-risk population.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11255-025-04720-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A pediatric-onset case of chronic kidney disease caused by a novel sporadic variant and literature review.
Turk J Pediatr
September 2025
West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Background: The α-actinin-4 (ACTN4) gene encodes an actin-binding protein, which plays a crucial role in maintaining the structure and function of podocytes. Previous studies have confirmed that ACTN4 mutations can lead to focal segmental glomerulosclerosis-1 (FSGS1), a rare disease primarily manifesting in adolescence or adulthood, characterized by mild to moderate proteinuria, with some cases progressing slowly to end-stage renal disease.
Case Presentation: We report a 12.
Identifying Factors Associated with Subsequent Diagnosis of Adrenal Adenoma: a population-based historical case-control study.
Eur J Endocrinol
September 2025
Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, 55905.
Objective: Identify social/metabolic risk factors associated with subsequent diagnosis of adrenal adenoma.
Design: Population-based historical case-control study.
Methods: Cases were adult patients diagnosed with an adrenal adenoma between 2005-2017 with no overt hormone excess.
A 12-Year Analysis of Equity and Efficiency in Living Kidney Donation at a Rural American Center.
Clin Transplant
September 2025
Avera Medical Group Transplant & Liver Surgery, Avera McKennan Hospital & University Health Center, Sioux Falls, South Dakota, USA.
Background: In the United States, a severe organ shortage precipitates an extensive transplant waitlist. Living donor kidneys are functionally superior to those from deceased donors and offer an alternative to close the supply-demand gap.
Methods: A retrospective review of 2147 patients who self-referred to begin the living kidney donation workup process at our center between June 1, 2012, and October 1, 2023 was conducted with subsequent statistical analysis of gathered data.
Cohort profile: The Multiethnic Lifestyle, Obesity and Diabetes Registry in Malaysia (MeLODY) retrospective cohort in a middle-income country in Southeast Asia.
PLoS One
September 2025
Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
There is a lack of longitudinal data on type 2 diabetes (T2D) in low- and middle-income countries. We leveraged the electronic health records (EHR) system of a publicly funded academic institution to establish a retrospective cohort with longitudinal data to facilitate benchmarking, surveillance, and resource planning of a multi-ethnic T2D population in Malaysia. This cohort included 15,702 adults aged ≥ 18 years with T2D who received outpatient care (January 2002-December 2020) from Universiti Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia.
View Article and Find Full Text PDFIntegrating kidney function assessment into the clinical interpretation of plasma Alzheimer's disease biomarkers.
J Alzheimers Dis
September 2025
Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
As plasma biomarkers like p-tau217 move towards clinical use in Alzheimer's disease (AD), it is important to understand how kidney function may influence their accuracy. Even mild chronic kidney disease (CKD) can alter biomarker levels, potentially impacting test performance. While accounting for renal function may improve specificity, it could reduce sensitivity without greatly changing overall diagnostic accuracy.
View Article and Find Full Text PDF